Droxi vs Nabla

Nabla was one arm of a randomized trial of 238 physicians at a California academic health system, and its users spent 9.5% less time in notes than the control group. PubMed lists no paper on Droxi, and its claim that 38% of routine work is handled automatically is the vendor's own figure. The two also answer different problems. Droxi handles the primary care inbox where Nabla handles the visit note. A primary care group on athenahealth or eClinicalWorks, where the vendor says Droxi runs natively, would buy it to summarize faxed documents, draft plain-language lab notes and pull chart context for refill requests. A health system that wants ambient notes, coding suggestions and dictation the vendor says is built into Epic would buy Nabla, which lists SOC 2 Type II and ISO 27001. Nabla has no public price. Its terms of sale charge a monthly fee per authorized user, in euros before VAT. A medical director who must pick one pilot and wants trial data behind it puts Droxi second.